Healthcare -
Biotechnology - NASDAQ - US
$ 20.59
0.869 %
$ 15.2 B
Market Cap
-58.03
P/E
SMMT - NET INCOME
Net Income SMMT - Summit Therapeutics Inc.
-221 M
LAST VALUE
-67.61%
2 YEAR CAGR
-56.09%
5 YEAR CAGR
-27.78%
10 YEAR CAGR